DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Nishino M, Okamoto N, Tanaka A. , et al.
Different risk factors for bleeding and discontinuation between dabigatran and rivaroxaban.
J Cardiol 2016;
68 (02) 156-160
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.